SL Science Holding SLBT
NASDAQ SLBT
$1.21 +0.02 (+1.68%)
At close: Oct 28, 2026 · 4:00 PM EDT

SL Science Holding (SLBT) Net Cash Flow (2025 - 2026)

Updated

SL Science Holding's Net Cash Flow was $41.18 million in Q2 2026, compared with $147,787 a year earlier.

Analysis

SL Science Holding (SLBT) Net Cash Flow (2025 - 2026) Analysis & Trends

For FY2025, Net Cash Flow at SL Science Holding came in at -$3.11 million.

  • In earlier years, Net Cash Flow was $3.47 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,213.59 Bn 1,182.17 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 652.89 Bn 572.75 Bn 17.30 Bn -3.52 Bn
3 AbbVie 506.16 Bn 479.31 Bn 12.70 Bn -2.82 Bn
4 Merck 347.97 Bn 302.40 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 297.84 Bn 271.42 Bn - -
6 Astrazeneca 262.79 Bn 236.55 Bn 12.86 Bn -3.94 Bn
7 Amgen 244.26 Bn 199.66 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 197.57 Bn 171.68 Bn 6.22 Bn -4.43 Bn
9 Pfizer 168.03 Bn 114.97 Bn 10.94 Bn -722.00 Mn
10 SL Science Holding 2.64 Bn 2.62 Bn - 41.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.18 Mn
Mar 31, 2026 1,669.00
Jun 30, 2025 147,787.00
API Access

SL Science Holding Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=SLBT&period=max&api_key=YOUR_API_KEY